{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T13:17:43Z","timestamp":1779283063469,"version":"3.51.4"},"reference-count":30,"publisher":"Impact Journals, LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2012,3,31]]},"DOI":"10.18632\/oncotarget.461","type":"journal-article","created":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T21:50:23Z","timestamp":1442440223000},"page":"261-266","source":"Crossref","is-referenced-by-count":24,"title":["Essential role for telomerase in chronic myeloid leukemia induced by BCR-ABL in mice"],"prefix":"10.18632","volume":"3","author":[{"given":"Carolina","family":"Vicente-Due\u00f1as","sequence":"first","affiliation":[{"name":"Experimental Therapeutics and Translational Oncology Program, Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer, CSIC\/ Universidad de Salamanca, SALAMANCA, (SPAIN)"},{"name":"Institute of Biomedical Research of Salamanca (IBSAL)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos","family":"Barajas-Diego","sequence":"additional","affiliation":[{"name":"Experimental Therapeutics and Translational Oncology Program, Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer, CSIC\/ Universidad de Salamanca, SALAMANCA, (SPAIN)"},{"name":"Institute of Biomedical Research of Salamanca (IBSAL)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Romero-Camarero","sequence":"additional","affiliation":[{"name":"Experimental Therapeutics and Translational Oncology Program, Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer, CSIC\/ Universidad de Salamanca, SALAMANCA, (SPAIN)"},{"name":"Institute of Biomedical Research of Salamanca (IBSAL)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00e9s","family":"Gonz\u00e1lez-Herrero","sequence":"additional","affiliation":[{"name":"Experimental Therapeutics and Translational Oncology Program, Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer, CSIC\/ Universidad de Salamanca, SALAMANCA, (SPAIN)"},{"name":"Institute of Biomedical Research of Salamanca (IBSAL)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Flores","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Research of Salamanca (IBSAL)"},{"name":"Departamento de Anatom\u00eda Patol\u00f3gica, Universidad de Salamanca"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isidro","family":"S\u00e1nchez-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Experimental Therapeutics and Translational Oncology Program, Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer, CSIC\/ Universidad de Salamanca, SALAMANCA, (SPAIN)"},{"name":"Institute of Biomedical Research of Salamanca (IBSAL)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2012,3,8]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0168-9525(96)30016-4","article-title":"Is telomerase activity in cancer due to selection of stem cells and differentiation arrest?","volume":"12","author":"Greaves","year":"1996","journal-title":"Trends in genetics : TIG"},{"key":"2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/345458a0","article-title":"Telomeres shorten during ageing of human fibroblasts","volume":"345","author":"Greider","year":"1990","journal-title":"Nature"},{"key":"3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0092-8674(01)80006-4","article-title":"Telomere shortening and tumor formation by mouse cells lacking telomerase RNA","volume":"91","author":"Greider","year":"1997","journal-title":"Cell"},{"key":"4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/33345","article-title":"Essential role of mouse telomerase in highly proliferative organs","volume":"392","author":"DePinho","year":"1998","journal-title":"Nature"},{"key":"5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0092-8674(00)80580-2","article-title":"Longevity, stress response, and cancer in aging telomerase-deficient mice","volume":"96","author":"DePinho","year":"1999","journal-title":"Cell"},{"key":"6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ccr.2007.02.026","article-title":"Short telomeres limit tumor progression in vivo by inducing senescence","volume":"11","author":"Greider","year":"2007","journal-title":"Cancer cell"},{"key":"7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/emboj.2008.253","article-title":"Cancer induction by restriction of oncogene expression to the stem cell compartment","volume":"28","author":"Sanchez-Garcia","year":"2009","journal-title":"Embo J"},{"key":"8","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.4161\/cc.8.9.8217","article-title":"Stem-cell driven cancer: \u201chands-off\u201d regulation of cancer development","volume":"8","author":"Sanchez-Garcia","year":"2009","journal-title":"Cell Cycle"},{"key":"9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJMcibr0808031","article-title":"The crossroads of oncogenesis and metastasis","volume":"360","author":"Sanchez-Garcia","year":"2009","journal-title":"The New England journal of medicine"},{"key":"10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.semcancer.2010.05.001","article-title":"Getting to the stem of cancer","volume":"20","author":"Sanchez-Garcia","year":"2010","journal-title":"Seminars in cancer biology"},{"key":"11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.semcancer.2010.02.001","article-title":"Cancer as a reprogramming-like disease: implications in tumor development and treatment","volume":"20","author":"Sanchez-Garcia","year":"2010","journal-title":"Semin Cancer Biol"},{"key":"12","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/carcin\/bgq062","article-title":"Bcl2 is not required for the development and maintenance of leukemia stem cells in mice","volume":"31","author":"Sanchez-Garcia","year":"2010","journal-title":"Carcinogenesis"},{"key":"13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro","volume":"99","author":"Holyoake","year":"2002","journal-title":"Blood"},{"key":"14","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1182\/blood-2004-04-1335","article-title":"Discontinuation of imatinib therapy after achieving a molecular response","volume":"104","author":"Kantarjian","year":"2004","journal-title":"Blood"},{"key":"15","doi-asserted-by":"crossref","first-page":"757","DOI":"10.6004\/jnccn.2005.0045","article-title":"Resistance to imatinib: mechanisms and management","volume":"3","author":"Deininger","year":"2005","journal-title":"Journal of the National Comprehensive Cancer Network: JNCCN"},{"key":"16","doi-asserted-by":"crossref","first-page":"16870","DOI":"10.1073\/pnas.0606509103","article-title":"Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice","volume":"103","author":"Li","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"17","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/sj.leu.2404609","article-title":"Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies","volume":"21","author":"Eaves","year":"2007","journal-title":"Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K"},{"key":"18","doi-asserted-by":"crossref","first-page":"14907","DOI":"10.1073\/pnas.0606176103","article-title":"Bim and Bad mediate imatinib-induced killing of Bcr\/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic","volume":"103","author":"Strasser","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"19","doi-asserted-by":"crossref","first-page":"14651","DOI":"10.1073\/pnas.0607135103","article-title":"Imatinib spells BAD news for Bcr\/abl-positive leukemias","volume":"103","author":"Kaufmann","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"20","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Sawyers","year":"2001","journal-title":"The New England journal of medicine"},{"key":"21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/jnci\/91.2.163","article-title":"In vivo eradication of human BCR\/ABL-positive leukemia cells with an ABL kinase inhibitor","volume":"91","author":"Gambacorti-Passerini","year":"1999","journal-title":"Journal of the National Cancer Institute"},{"key":"22","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/sj.onc.1209968","article-title":"Sustained leukaemic phenotype after inactivation of BCR-ABLp190 in mice","volume":"26","author":"Sanchez-Garcia","year":"2007","journal-title":"Oncogene"},{"key":"23","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJM198105143042004","article-title":"Chronic myelogenous leukemia--new concepts (first of two parts)","volume":"304","author":"Golde","year":"1981","journal-title":"The New England journal of medicine"},{"key":"24","first-page":"441","article-title":"Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nature reviews","volume":"7","author":"Barnes","year":"2007","journal-title":"Cancer"},{"key":"25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ccr.2009.01.011","article-title":"The stem of cancer","volume":"15","author":"Fodde","year":"2009","journal-title":"Cancer cell"},{"key":"26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/emboj.2008.292","article-title":"Targeting a chronic problem: elimination of cancer stem cells in CML","volume":"28","author":"Nerlov","year":"2009","journal-title":"The EMBO journal"},{"key":"27","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Druker","year":"2011","journal-title":"The Journal of clinical investigation"},{"key":"28","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood-2010-12-326843","article-title":"Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival","volume":"119","author":"Holyoake","year":"2012","journal-title":"Blood"},{"issue":"Suppl 1","key":"29","first-page":"60","article-title":"Chronic myeloid leukemia stem cells and developing therapies","volume":"52","author":"Peterson","year":"2011","journal-title":"Leukemia & lymphoma"},{"key":"30","article-title":"The age of the target cell affects B-cell leukaemia malignancy","author":"Sanchez-Garcia","year":"2010","journal-title":"Aging (Albany NY)"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.461","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T13:31:23Z","timestamp":1594819883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,8]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["461","22408137"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.461","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,8]]}}}